UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis

Journal of musculoskeletal & neuronal interactions, 2008-04, Vol.8 (2), p.94-104

2008

Volltextzugriff (PDF)

Agonist-Specific Regulation of Parathyroid Hormone (PTH) Receptor Type 2 Activity: Structural and Functional Analysis of PTH- and Tuberoinfundibular Peptide (TIP) 39-Stimulated Desensitization and Internalization

Molecular endocrinology (Baltimore, Md.), 2004-06, Vol.18 (6), p.1486-1498

2004

Volltextzugriff (PDF)

Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL

The Journal of biological chemistry, 2010-09, Vol.285 (36), p.28164-28173

2010

Volltextzugriff (PDF)

Bone management in hematologic stem cell transplant recipients

Osteoporosis international, 2018-12, Vol.29 (12), p.2597-2610

2018

Volltextzugriff (PDF)

Cancer-associated bone disease

Osteoporosis international, 2013-12, Vol.24 (12), p.2929-2953

2013

Volltextzugriff (PDF)

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

Osteoporosis international, 2013-08, Vol.24 (8), p.2135-2152

2013

Volltextzugriff (PDF)

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

Journal of clinical densitometry, 2017, Vol.20 (1), p.8-24

2017

Volltextzugriff (PDF)

Diagnosis and management of bone fragility in diabetes: an emerging challenge

Osteoporosis international, 2018-12, Vol.29 (12), p.2585-2596

2018

Volltextzugriff (PDF)

Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool

Osteoporosis international, 2015-11, Vol.26 (11), p.2573-2578

2015

Volltextzugriff (PDF)

Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype

Endocrinology (Philadelphia), 1999-09, Vol.140 (9), p.4046-4055

1999

Volltextzugriff (PDF)

Global Consensus Statement on menopausal hormone therapy

Maturitas, 2013-04, Vol.74 (4), p.391-392

2013

Volltextzugriff (PDF)

Global Consensus Statement on Menopausal Hormone Therapy

Climacteric : the journal of the International Menopause Society, 2013-04, Vol.16 (2), p.203-204

2013

Volltextzugriff (PDF)

A global representation of vitamin D status in healthy populations

Archives of osteoporosis, 2012, Vol.7 (1-2), p.155-172

2012

Volltextzugriff (PDF)

A global representation of vitamin D status in healthy populations: reply to comment by Saadi

Archives of osteoporosis, 2013-12, Vol.8 (1-2), p.122-122, Article 122

2013

Volltextzugriff (PDF)

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Osteoporosis international, 2021-04, Vol.32 (4), p.611-617

2021

Volltextzugriff (PDF)

Infrequent Delivery of a Long‐Acting PTH‐Fc Fusion Protein Has Potent Anabolic Effects on Cortical and Cancellous Bone

Journal of bone and mineral research, 2007-10, Vol.22 (10), p.1534-1547

2007

Volltextzugriff (PDF)

MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus

European journal of endocrinology, 2016-04, Vol.174 (4), p.R127-R138

2016

Volltextzugriff (PDF)

Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans

Journal of bone and mineral research, 2011-08, Vol.26 (8), p.1891-1903

2011

Volltextzugriff (PDF)

Mechanisms of diabetes mellitus-induced bone fragility

Nature reviews. Endocrinology, 2017-04, Vol.13 (4), p.208-219

2017

Volltextzugriff (PDF)

Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures

Osteoporosis international, 2017-05, Vol.28 (5), p.1507-1529

2017

Volltextzugriff (PDF)

A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network

Osteoporosis international, 2020-07, Vol.31 (7), p.1193-1204

2020

Volltextzugriff (PDF)

Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk

Osteoporosis international, 2020-03, Vol.31 (3), p.393-408

2020

Volltextzugriff (PDF)

Response to Comments on “Diagnosis and Management of Osteoporosis of the Jaw: A Systematic Review and International Consensus”

Journal of bone and mineral research, 2015-06, Vol.30 (6), p.1116-1117

2015

Volltextzugriff (PDF)

Revised Global Consensus Statement on Menopausal Hormone Therapy

Climacteric : the journal of the International Menopause Society, 2016-07, Vol.19 (4), p.313-315

2016

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Endocrinology & Metabolism
(17)
Endocrinology
(13)
Medicine
(12)
Medicine & Public Health
(12)
Orthopedics
(12)
Osteoporosis
(11)
Female
(10)
Rheumatology
(10)
Osteoporosis - Drug Therapy
(9)
Animals
(8)
Fractures
(8)
Male
(8)
Risk Factors
(8)
Osteoporotic Fractures - Prevention & Control
(7)
Bone Density Conservation Agents - Therapeutic Use
(6)
Position Paper
(5)
Biological And Medical Sciences
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis

Agonist-Specific Regulation of Parathyroid Hormone (PTH) Receptor Type 2 Activity: Structural and Functional Analysis of PTH- and Tuberoinfundibular Peptide (TIP) 39-Stimulated Desensitization and Internalization

Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL

Bone management in hematologic stem cell transplant recipients

Cancer-associated bone disease

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

Diagnosis and management of bone fragility in diabetes: an emerging challenge

Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool

Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype

Global Consensus Statement on menopausal hormone therapy

Global Consensus Statement on Menopausal Hormone Therapy

A global representation of vitamin D status in healthy populations

A global representation of vitamin D status in healthy populations: reply to comment by Saadi

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Infrequent Delivery of a Long‐Acting PTH‐Fc Fusion Protein Has Potent Anabolic Effects on Cortical and Cancellous Bone

MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus

Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans

Mechanisms of diabetes mellitus-induced bone fragility

Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures

A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network

Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk

Response to Comments on “Diagnosis and Management of Osteoporosis of the Jaw: A Systematic Review and International Consensus”

Revised Global Consensus Statement on Menopausal Hormone Therapy

Aktive Filter

Suchergebnisse filtern